In focus · trending topic

Chronic Kidney Disease

11 stories · following the connections

DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease

By Nasdaq OMXMay 3, 2018, 12:30 PM UTC

Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients

By Nasdaq OMXMay 1, 2018, 11:35 AM UTC

DiaMedica Therapeutics Announces Final Closing of Private Placement

By Nasdaq OMXMar 29, 2018, 10:08 PM UTC

DiaMedica Therapeutics Announces Closing of Private Placement

By Nasdaq OMXMar 20, 2018, 9:40 PM UTC

DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke

By Nasdaq OMXFeb 22, 2018, 12:00 PM UTC

DiaMedica to Present at the 14th Annual Noble Investor Conference

By Nasdaq OMXJan 29, 2018, 1:45 PM UTC

Streetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’

By Nasdaq OMXDec 7, 2017, 1:45 PM UTC

Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference

By Nasdaq OMXOct 31, 2017, 1:03 PM UTC